ROSE MAXIME: Open Payments
NPI 1700242468 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 19 payments from 5 companies in 2025. Trend: 2023 $377 · 2024 $191 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $313 |
| ABBVIE INC. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Alkermes, Inc. | 1 | $25 |
Products named: CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, FANAPT, ARISTADA.
Industry payments across FL — which companies pay providers there.
